SCHEMBL7698017

SCHEMBL7698017

CC(C)(C)OC(=O)Nc1ccc(NC(=O)CN)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.52
CA1 P00915 3/20 0.50
CA2 P00918 2/20 0.50
PTPN11 Q06124 1/20 0.48
LTA4H P09960 1/20 0.48
PSMB8 P28062 1/20 0.47
NAMPT P43490 1/20 0.47
MAPKAPK2 P49137 3/20 0.46
MAP4K4 O95819 1/20 0.46
HDAC3 O15379 3/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC1 Q13547 2/20 0.46
NCOR2 Q9Y618 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
TERT O14746 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13055402 0.86 CYP17A1 (0.59) CYP17A1CA1PTPN11PSMB8NAMPT
SCHEMBL21781875 0.85 CYP17A1 (0.52) CYP17A1CA1CA2PTPN11NAMPT
SCHEMBL15692011 0.85 NAMPT (0.58) CYP17A1CA1CA2PTPN11LTA4H
SCHEMBL12130299 0.85 CYP17A1 (0.54) CYP17A1CA1CA2PSMB8NAMPT
SCHEMBL14116517 0.84 MEN1 (0.54) CA1CA2LTA4HCA12CA9
SCHEMBL16927179 0.83 CYP17A1 (0.52) CYP17A1CA1CA2PTPN11PSMB8
SCHEMBL7079572 0.83 CYP17A1 (0.52) CYP17A1CA1CA2PTPN11PSMB8
SCHEMBL14861108 0.83 CYP17A1 (0.52) CYP17A1CA1CA2PTPN11PSMB8
SCHEMBL13193491 0.83 CYP17A1 (0.52) CYP17A1CA1CA2PTPN11PSMB8
SCHEMBL34480 0.83 CYP17A1 (0.59) CYP17A1PSMB8NAMPTMAPKAPK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479488-B1 GOOD IN VITRO AFFINITY FOR THE STRYCHNINE INSENSITIVE GLYCINE BINDING SITE ASSOCIATED WITH THE NMDA RECEPTOR COMPLEX BUT ALSO GOOD IN VIVO ACTIVITY WHEN ADMINISTERED SYSTEMICALLY GLAXO WELLCOME SPA (IT) 2002-11-12 US disclosed